Revolutionizing Healthcare with Wearable Continuous Molecular Monitoring with Peter Vranes, Co-CEO & Co- Founder at Nutromics
In this Outcomes Rocket MedTech podcast, we are excited to feature Peter Vranes, CEO & Co-Founder of Nutromics, an Australian medtech company revolutionizing healthcare through continuous real-time molecular monitoring.
Peter discusses how Nutromic’s smart patch biosensor solves some of the healthcare challenges in chronic disease prevention and management, acute diseases, and therapeutic drug monitoring. He shares the lightbulb moment which led to the creation of Nutromic, dives into vancomycin, what happens when patients have overdosed, and how the smart patch can help clinicians have accurate, real-time data, continuous monitoring of vancomycin. He also talks about therapeutic drug monitoring for a whole range of drugs, the benefits for both physicians and patients, and the different pivots the company did that led to the smart patch. Peter also shares his insights on being transparent and building relationships of trust with VCs. The company is preparing for a clinical trial in a few months and has closed a 7.5 multimillion-dollar grant.
Click this link to the show notes, transcript, and resources: outcomesrocket.health
